Clinical Trials

    Showing 1 - 3 of 3 Urinary Tract Cancers

    A phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Naive, High Grade Non-Muscle Invasive Bladder Cancer.

    Status: Open Not Enrolling

    Investigator: Raj Satkunasivam

    Study Coordinator: Taliah Muhammad

    Phone: 346.238.4523

    This randomized phase III trial studies Tokyo-172 strain bacillus Calmette-Guerin (BCG) solution with or without a vaccination using Tokyo-172 strain BCG to see how well it works compared with TICE BCG solution in treating patients with bladder cance... Read more >

    A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

    Status: Enrolling

    Investigator: Patrick Prath

    Study Coordinator: Syeda Sarwat

    Phone: 832.358.4365

    This phase III trial compares the effectiveness of pembrolizumab and sacituzumab govitean-hziy to standard of care in treating patients with urothelial cancer that has spread to nearby tissue or lymph nodes (locally advanced) or that has spread to ot... Read more >

    Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST)

    Status: Open Not Enrolling

    Investigator: Dharam Kaushik

    Study Coordinator: Taliah Muhammad

    Phone: 346.238.4523

    Primary Purpose: Treatment... Read more >